TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

Currently, several states have outbreaks. In Kansas City, where cases have increased 148%, two deaths have been reported ...

ICMR soon to begin landmark TB study testing high-dose rifampicin regimens: Shardul Nautiyal, Mumbai Tuesday, May 13, 2025, ...

Anti-tuberculosis drug-induced acute kidney injury is not rare in an aging population. It usually develops within two months of treatment and resolves within three months after onset. Although ...

A starry sky can be stunning—even inside a hospital emergency room.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

Kampala, Uganda | THE INDEPENDENT | Quality Chemical Industries Limited (Qcil) is set to construct a second factory after it ...